TERT and cancer: Beyond a relatively small number of hotspots (e.g., the TERT promoter, which is known to be highly mutated across cancer types [8–10]) the majority of the identified hotspots (n = 281, 70%) are exclusively mutated in melanoma alone [Fig. 3c].